Mode
Text Size
Log in / Sign up
Phase 4 Completed N=6 Prevention

Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery

Bariatric Surgery Candidate
Source: ClinicalTrials.gov NCT03424239 ↗
Enrolled (actual)
6
Serious AEs
25.0%
Results posted
Apr 2021
Primary outcomePrimary: Change in Serum CTX — 0.228 ng/ml
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

This study evaluates whether zoledronic acid can prevent the high bone turnover that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Serum CTX
0.228
SECONDARY
Change in Total Hip Bone Mineral Density by DXA
-0.039
SECONDARY
Change in Trabecular Spine Bone Mineral Density by QCT
4.9
SECONDARY
Number of Participants With Treatment-related Hypocalcemia Events as Assessed by CTCAE v4.0
SECONDARY
Change From Baseline of Femoral Neck Bone Density Measured by DXA
-0.038
SECONDARY
Change From Baseline of Spine Bone Density Measured by DXA
0.003

Eligibility Criteria

Inclusion Criteria

  • Men must be age ≥ 50
  • Women must be age ≥ 25 and postmenopausal
  • Planning to receive RYGB or SG surgery

Exclusion Criteria

  • Age < 25
  • Prior bariatric surgery
  • Weight ≥ 400 lbs
  • Liver or renal disease
  • Hypercalcemia, hypocalcemia, or hypomagnesemia
  • Serum 25-hydroxyvitamin D < 20 ng/mL
  • History of bone-modifying disorders
  • Use of bone-active medications
  • Known sensitivity to bisphosphonates
  • Extensive dental work involving extraction or dental implant within the past 2 months or planned in the upcoming 6 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03424239). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search